Novonesis, DK0060336014

Novonesis stock gains 1.13 percent ahead of the open

Published on 09/25/2026 at 03:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Novonesis stock reached DKK 443.30 in Copenhagen, 0.56 percent below its 52-week high. JPMorgan named the shares its top long in European chemicals.

Industrieanlage mit Fermentationstanks eines daenischen Biotech-Unternehmens
Fotorealistische Ansicht einer Biotech-Anlage von Novonesis (Novozymes), ISIN DK0060336014, mit modernen Fermentationstanks in Bagsvaerd, Illustration mit AI erstellt.

Novonesis stock closed at DKK 443.30 on Nasdaq Copenhagen on September 24, 2026, gaining 1.13 percent. The shares finished 0.56 percent below their 52-week high of DKK 445.80, providing the key quantified comparison for the session.

September 24, 2026 in numbers

Novonesis A/S (ISIN DK0060336014) ended the session at DKK 443.30, according to the dated market report, after rising 1.13 percent on Nasdaq Copenhagen. The reported 52-week range was DKK 437.50 to DKK 445.80, placing the close DKK 5.80 above the low and DKK 2.50 below the high.

The move followed JPMorgan naming Novonesis its top long in European chemicals on September 24, 2026. As Investing.com reported, the bank cited the companys structural organic growth profile and more than 20 percent post-tax return on invested capital.

Today before the open

JPMorgans sector preference is the most recent company-specific market signal available for Novonesis ahead of the September 25, 2026 session. The shares enter the session close to their 52-week high, with the last completed Copenhagen close dated September 24, 2026.

Disclaimer...

en | DK0060336014 | NOVONESIS | boerse | 70180215 | bgmi